September 5, 2013 / 11:14 AM / 4 years ago

Medical isotope maker Nordion's profit jumps due to gain from unit sale

Sept 5 (Reuters) - Canada’s Nordion Inc, a provider of isotopes used in medical imaging, reported a huge jump in third-quarter profit after it recorded an after-tax gain of about $182 million on the sale of its targeted therapies business.

Net profit rose to $180.4 million, or $2.91 per share, from $12.3 million, or 20 cents per share, a year earlier.

Revenue rose 7 percent to $71.7 million.

Nordion completed in July the sale of its targeted therapies division, which includes the liver cancer therapy TheraSphere, to British health care company BTG Plc.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below